| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977380 | Brachytherapy | 2010 | 6 Pages |
Abstract
Dose escalation of IMRT by adding HDR brachytherapy provided improved PRFS in the treatment of prostate cancer compared with ultra-high-dose IMRT, independent of risk group on multivariate analysis, with the most significant benefit for intermediate-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Israel Deutsch, Michael J. Zelefsky, Zhigang Zhang, Qianxing Mo, Marco Zaider, Gil'ad Cohen, Oren Cahlon, Yoshiya Yamada,